(Q57701924)

Giuseppe Remuzzi

15

0 references

Marina Noris

14

Marina Noris

0 references

Elena Gagliardini

7

Elena Gagliardini

0 references

Sistiana Aiello

10

Sistiana Aiello

0 references

Norberto Perico

13

Norberto Perico

0 references

Anna Pezzotta

5

Anna Pezzotta

0 references

Marilena Mister

4

Marilena Mister

0 references

Daniela Cugini

8

Daniela Cugini

0 references

Lorenzo Gallon

2

Lorenzo Gallon

0 references

Samantha Solini

6

Samantha Solini

0 references

Federica Rocchetta

11

Federica Rocchetta

0 references

author name string

Paola Cassis

1

0 references

Mauro Abbate

9

0 references

Pierangela Scudeletti

https://scigraph.springernature.com/pub.10.1038/ki.2011.473

12

0 references

language of work or name

English

0 references

publication date

May 2012

0 references

published in

Kidney International

0 references

volume

81

0 references

issue

9

0 references

page(s)

903-918

0 references

exact match

0 references

cites work

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Assessing long-term nephron loss: is it time to kick the CAN grading system?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Chronic renal allograft rejection: pathophysiologic considerations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Anemia is associated with mortality in kidney-transplanted patients--a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Hypoxia-induced changes in extracellular matrix metabolism in renal cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Protective effect of Epo on oxidative renal injury in rats with cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Erythropoietin therapy may retard progression in chronic renal transplant dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Use of recombinant human erythropoietin in kidney transplant patients with stable graft function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

The non-haematopoietic biological effects of erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Long-term erythropoietin in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Posttransplant anemia in solid organ recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Expression of inducible and endothelial nitric oxide synthases, formation of peroxynitrite and reactive oxygen species in human chronic renal transplant failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Rejection of peritubular capillaries in renal allo- and xeno-graft

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Human, rat, and mouse kidney cells express functional erythropoietin receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Recombinant human erythropoietin stimulates angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Recombinant human erythropoietin stimulates vascular endothelial growth factor release by glomerular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Angiopoietins and angiopoietin-like proteins in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Expression and distribution of epidermal growth factor in acute and chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Differential expression of profibrotic and growth factors in chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Erythropoietin protects against ischaemic acute renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Derivatives of erythropoietin that are tissue protective but not erythropoietic

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Critical roles of the PI3K/Akt signaling pathway in T cell development

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Late kidney allograft loss: what we know about it, and what we can do about it

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

The contribution of podocytes to chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

A role for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: the start of a good news/bad news story?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Efficacy and safety of epoetin alfa in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021

Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.473

7 January 2021